Rifaximin systemic absorption in patients with ulcerative colitis

被引：43

作者：

Rizzello, F

Gionchetti, P

Venturi, A

Ferretti, M

Peruzzo, S

Raspanti, X

Picard, M

Canova, N

Palazzini, E

Campieri, M

机构：

[1] Alfa Wassermann SPA, Dept Med, I-40133 Bologna, Italy

[2] St Orsola Univ Hosp, Dept Clin Med & Gastroenterol, Bologna, Italy

[3] Larime SA, Lab Rech Ind Medicament, Lagord, France

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1998年 / 54卷 / 01期

关键词：

ulcerative colitis; rifaximin;

D O I：

10.1007/s002280050426

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：91 / 93

页数：3

共 14 条

[1] VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS [J].

BARON, JH ;

CONNELL, AM ;

LENNARDJONES, JE .

BRITISH MEDICAL JOURNAL, 1964, 1 (5374) :89-+

[2]

BURKE DA, 1990, ALIMENT PHARM THERAP, V4, P123

[3]

CAHDWICK VS, 1992, INFLAMM BOWEL DIS, P241

[4] CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J].

CHAPMAN, RW ;

SELBY, WS ;

JEWELL, DP .

GUT, 1986, 27 (10) :1210-1212

[5]

DESCOMBE JJ, 1994, INT J CLIN PHARM RES, V14, P51

[6] DOUBLE-BLIND CONTROLLED TRIAL OF ORAL VANCOMYCIN AS ADJUNCTIVE TREATMENT IN ACUTE EXACERBATIONS OF IDIOPATHIC COLITIS [J].

DICKINSON, RJ ;

OCONNOR, HJ ;

PINDER, I ;

HAMILTON, I ;

JOHNSTON, D ;

AXON, ATR .

GUT, 1985, 26 (12) :1380-1384

[7] RIFAXIMIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN CONDITIONS MEDIATED BY GASTROINTESTINAL BACTERIA [J].

GILLIS, JC ;

BROGDEN, RN .

DRUGS, 1995, 49 (03) :467-484

[8]

GIONCHETTI P, 1997, IN PRESS DIG DIS SCI

[9] ANTIMICROBIAL ACTIVITY AND SPECTRUM OF RIFAXIMIN, A NEW TOPICAL RIFAMYCIN DERIVATIVE [J].

HOOVER, WW ;

GERLACH, EH ;

HOBAN, DJ ;

ELIOPOULOS, GM ;

PFALLER, MA ;

JONES, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 16 (02) :111-118

[10]

MANTZARIS GJ, 1994, AM J GASTROENTEROL, V89, P43

← 1 2 →